Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme
- PMID: 1726123
- DOI: 10.1016/0196-9781(91)90220-j
Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme
Abstract
In addition to plasma metabolism of substance P (SP) by angiotensin converting enzyme (ACE; EC 3.4.15.1) (less than 1.0 nmol/min/ml), the majority of SP hydrolysis by rat and human plasma was due to dipeptidyl(amino)peptidase IV (DAP IV; EC 3.4.14.5) (3.15-5.91 nmol/min/ml), which sequentially converted SP to SP(3-11) and SP(5-11). In turn, the SP(5-11) metabolite was rapidly hydrolyzed by rat and human plasma aminopeptidase M (AmM; EC 3.4.11.2) (24.2-25.5 nmol/min/ml). The Km values of SP for DAP IV and of SP(5-11) for AmM ranged from 32.7 to 123 microM. In contrast, neurokinin A (NKA) was resistant to both ACE and DAP IV but was subject to N-terminal hydrolysis by AmM (3.76-10.8 nmol/min/ml; Km = 90.7 microM). These data demonstrate differential processing of SP and NKA by specific peptidases in rat and human plasma.
Similar articles
-
Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo.J Pharmacol Exp Ther. 1992 Mar;260(3):1257-61. J Pharmacol Exp Ther. 1992. PMID: 1372050
-
Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle.Peptides. 1994;15(3):497-503. doi: 10.1016/0196-9781(94)90212-7. Peptides. 1994. PMID: 7524048
-
Immunoelectrophoretic analysis of vascular, membrane-bound angiotensin I converting enzyme, aminopeptidase M, and dipeptidyl(amino)peptidase IV.Biochem Pharmacol. 1984 Oct 15;33(20):3183-93. doi: 10.1016/0006-2952(84)90075-3. Biochem Pharmacol. 1984. PMID: 6148948
-
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.Peptides. 2004 Mar;25(3):521-5. doi: 10.1016/j.peptides.2003.12.010. Peptides. 2004. PMID: 15134871 Review.
-
Research Progress on Dipeptidyl Peptidase Family: Structure, Function and Xenobiotic Metabolism.Curr Med Chem. 2022;29(12):2167-2188. doi: 10.2174/0929867328666210915103431. Curr Med Chem. 2022. PMID: 34525910 Review.
Cited by
-
Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.Hypertension. 2014 May;63(5):951-7. doi: 10.1161/HYPERTENSIONAHA.113.02767. Epub 2014 Feb 10. Hypertension. 2014. PMID: 24516103 Free PMC article. Clinical Trial.
-
Microbial dipeptidyl peptidases of the S9B family as host-microbe isozymes.Sci Adv. 2025 Apr 4;11(14):eads5721. doi: 10.1126/sciadv.ads5721. Epub 2025 Apr 2. Sci Adv. 2025. PMID: 40173242 Free PMC article. Review.
-
Hydrolysis of substance P in the presence of the osteosarcoma cell line SaOS-2: release of free amino acids.Neurochem Res. 2011 Dec;36(12):2339-45. doi: 10.1007/s11064-011-0559-2. Epub 2011 Aug 21. Neurochem Res. 2011. PMID: 21858699
-
Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and aminopeptidase P in rat paws.Naunyn Schmiedebergs Arch Pharmacol. 1996 Nov;354(5):670-6. doi: 10.1007/BF00170844. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8938668
-
The role of substance p in ischaemic brain injury.Brain Sci. 2013 Jan 30;3(1):123-42. doi: 10.3390/brainsci3010123. Brain Sci. 2013. PMID: 24961310 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous